Ansell Limited
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, single-use and examination gloves,… Read more
Ansell Limited (ANSLF) - Net Assets
Latest net assets as of June 2025: $1.98 Billion USD
Based on the latest financial reports, Ansell Limited (ANSLF) has net assets worth $1.98 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.32 Billion) and total liabilities ($1.34 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.98 Billion |
| % of Total Assets | 59.68% |
| Annual Growth Rate | 3.19% |
| 5-Year Change | 26.72% |
| 10-Year Change | 74.08% |
| Growth Volatility | 22.88 |
Ansell Limited - Net Assets Trend (1989–2025)
This chart illustrates how Ansell Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ansell Limited (1989–2025)
The table below shows the annual net assets of Ansell Limited from 1989 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $1.98 Billion | +3.80% |
| 2024-06-30 | $1.91 Billion | +18.53% |
| 2023-06-30 | $1.61 Billion | +3.55% |
| 2022-06-30 | $1.56 Billion | -0.53% |
| 2021-06-30 | $1.56 Billion | +11.39% |
| 2020-06-30 | $1.40 Billion | -0.02% |
| 2019-06-30 | $1.40 Billion | -9.03% |
| 2018-06-30 | $1.54 Billion | +25.95% |
| 2017-06-30 | $1.23 Billion | +7.66% |
| 2016-06-30 | $1.14 Billion | +28.39% |
| 2015-06-30 | $887.13 Million | -17.20% |
| 2014-06-30 | $1.07 Billion | +52.43% |
| 2013-06-30 | $702.94 Million | -5.81% |
| 2012-06-30 | $746.33 Million | -3.64% |
| 2011-06-30 | $774.54 Million | +62.71% |
| 2010-06-30 | $476.02 Million | +15.44% |
| 2009-06-30 | $412.34 Million | -17.78% |
| 2008-06-30 | $501.52 Million | +13.70% |
| 2007-06-30 | $441.07 Million | +23.20% |
| 2006-06-30 | $358.03 Million | +2.86% |
| 2005-06-30 | $348.07 Million | -12.85% |
| 2004-06-30 | $399.39 Million | +3.38% |
| 2003-06-30 | $386.33 Million | +38.77% |
| 2002-06-30 | $278.40 Million | -0.46% |
| 2001-06-30 | $279.68 Million | -47.96% |
| 2000-06-30 | $537.47 Million | -25.91% |
| 1999-06-30 | $725.48 Million | +11.92% |
| 1998-06-30 | $648.19 Million | -37.89% |
| 1997-06-30 | $1.04 Billion | -6.32% |
| 1996-06-30 | $1.11 Billion | -2.49% |
| 1995-06-30 | $1.14 Billion | -9.35% |
| 1994-06-30 | $1.26 Billion | +28.39% |
| 1993-06-30 | $981.51 Million | -14.05% |
| 1992-06-30 | $1.14 Billion | +40.26% |
| 1991-06-30 | $814.20 Million | +1.76% |
| 1990-06-30 | $800.10 Million | +25.10% |
| 1989-06-30 | $639.58 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ansell Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 115113120000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $1.10 Billion | 55.88% |
| Common Stock | $1.03 Billion | 52.30% |
| Other Comprehensive Income | $-160.60 Million | -8.18% |
| Total Equity | $1.96 Billion | 100.00% |
Ansell Limited Competitors by Market Cap
The table below lists competitors of Ansell Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Atco Ltd
PINK:ACLLF
|
$2.59 Billion |
|
Cngr Advanced Material Co Ltd
SHE:300919
|
$2.59 Billion |
|
GS Yuasa Corporation
F:G9Y
|
$2.59 Billion |
|
Beijing Enlight Media
SHE:300251
|
$2.59 Billion |
|
Dr. Ing. h.c. F. Porsche AG
PINK:DRPRF
|
$2.58 Billion |
|
Sichuan Biokin Pharmaceutical Co. Ltd. A
SHG:688506
|
$2.58 Billion |
|
Metaplanet Inc.
PINK:MTPLF
|
$2.58 Billion |
|
Fortress Transportation and Preferred Series B
NASDAQ:FTAIO
|
$2.58 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ansell Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,894,900,000 to 1,963,600,000, a change of 68,700,000 (3.6%).
- Net income of 101,600,000 contributed positively to equity growth.
- Dividend payments of 63,700,000 reduced retained earnings.
- Share repurchases of 4,400,000 reduced equity.
- Other comprehensive income increased equity by 32,138,579.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $101.60 Million | +5.17% |
| Dividends Paid | $63.70 Million | -3.24% |
| Share Repurchases | $4.40 Million | -0.22% |
| Other Comprehensive Income | $32.14 Million | +1.64% |
| Other Changes | $3.06 Million | +0.16% |
| Total Change | $- | 3.63% |
Book Value vs Market Value Analysis
This analysis compares Ansell Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.34x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.58x to 1.34x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1989-06-30 | $3.93 | $18.00 | x |
| 1990-06-30 | $4.83 | $18.00 | x |
| 1991-06-30 | $4.85 | $18.00 | x |
| 1992-06-30 | $5.68 | $18.00 | x |
| 1993-06-30 | $4.22 | $18.00 | x |
| 1994-06-30 | $5.76 | $18.00 | x |
| 1995-06-30 | $5.16 | $18.00 | x |
| 1996-06-30 | $5.30 | $18.00 | x |
| 1997-06-30 | $5.01 | $18.00 | x |
| 1998-06-30 | $3.09 | $18.00 | x |
| 1999-06-30 | $3.50 | $18.00 | x |
| 2000-06-30 | $2.55 | $18.00 | x |
| 2001-06-30 | $1.41 | $18.00 | x |
| 2002-06-30 | $1.54 | $18.00 | x |
| 2003-06-30 | $2.05 | $18.00 | x |
| 2004-06-30 | $2.18 | $18.00 | x |
| 2005-06-30 | $2.05 | $18.00 | x |
| 2006-06-30 | $2.19 | $18.00 | x |
| 2007-06-30 | $2.87 | $18.00 | x |
| 2008-06-30 | $3.46 | $18.00 | x |
| 2009-06-30 | $2.92 | $18.00 | x |
| 2010-06-30 | $3.47 | $18.00 | x |
| 2011-06-30 | $5.71 | $18.00 | x |
| 2012-06-30 | $5.57 | $18.00 | x |
| 2013-06-30 | $5.25 | $18.00 | x |
| 2014-06-30 | $7.36 | $18.00 | x |
| 2015-06-30 | $5.67 | $18.00 | x |
| 2016-06-30 | $7.38 | $18.00 | x |
| 2017-06-30 | $8.09 | $18.00 | x |
| 2018-06-30 | $10.48 | $18.00 | x |
| 2019-06-30 | $10.13 | $18.00 | x |
| 2020-06-30 | $10.53 | $18.00 | x |
| 2021-06-30 | $11.92 | $18.00 | x |
| 2022-06-30 | $12.03 | $18.00 | x |
| 2023-06-30 | $12.57 | $18.00 | x |
| 2024-06-30 | $14.64 | $18.00 | x |
| 2025-06-30 | $13.44 | $18.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ansell Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.17%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.07%
- • Asset Turnover: 0.60x
- • Equity Multiplier: 1.69x
- Recent ROE (5.17%) is below the historical average (6.25%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1989 | -44.39% | -6.20% | 1.90x | 3.76x | $-341.08 Million |
| 1990 | -6.30% | -0.98% | 1.90x | 3.38x | $-128.49 Million |
| 1991 | -2.31% | -0.49% | 1.38x | 3.40x | $-98.75 Million |
| 1992 | -2.13% | -0.55% | 1.30x | 2.96x | $-136.69 Million |
| 1993 | -0.40% | -0.09% | 1.46x | 2.99x | $-100.65 Million |
| 1994 | -0.30% | -0.07% | 1.41x | 2.89x | $-128.06 Million |
| 1995 | -0.57% | -0.12% | 1.48x | 3.15x | $-118.21 Million |
| 1996 | -0.45% | -0.08% | 1.75x | 3.39x | $-113.94 Million |
| 1997 | -0.52% | -0.09% | 1.95x | 3.09x | $-107.70 Million |
| 1998 | 0.10% | 0.00% | 0.00x | 3.21x | $-63.20 Million |
| 1999 | -0.59% | 0.00% | 0.00x | 3.24x | $-75.61 Million |
| 2000 | -0.46% | 0.00% | 0.00x | 3.43x | $-55.57 Million |
| 2001 | -0.67% | -0.04% | 4.56x | 3.32x | $-29.29 Million |
| 2002 | -0.58% | -0.13% | 2.15x | 2.13x | $-28.98 Million |
| 2003 | -0.46% | -0.20% | 1.21x | 1.89x | $-39.89 Million |
| 2004 | -0.34% | -0.17% | 1.06x | 1.87x | $-40.76 Million |
| 2005 | -0.40% | -0.16% | 1.21x | 2.02x | $-35.65 Million |
| 2006 | 33.14% | 10.20% | 1.59x | 2.04x | $81.06 Million |
| 2007 | 19.72% | 8.07% | 1.17x | 2.09x | $41.81 Million |
| 2008 | 20.04% | 8.24% | 1.12x | 2.17x | $49.18 Million |
| 2009 | 24.32% | 8.98% | 1.29x | 2.10x | $57.68 Million |
| 2010 | 21.77% | 9.70% | 1.13x | 1.99x | $54.87 Million |
| 2011 | 17.28% | 10.06% | 0.94x | 1.83x | $55.25 Million |
| 2012 | 18.18% | 10.67% | 0.89x | 1.91x | $59.87 Million |
| 2013 | 18.12% | 10.21% | 0.79x | 2.25x | $55.96 Million |
| 2014 | 3.95% | 2.80% | 0.67x | 2.10x | $-63.89 Million |
| 2015 | 16.28% | 8.67% | 0.91x | 2.06x | $55.00 Million |
| 2016 | 14.16% | 11.47% | 0.60x | 2.04x | $46.78 Million |
| 2017 | 12.22% | 10.59% | 0.57x | 2.02x | $26.86 Million |
| 2018 | 8.67% | 9.36% | 0.56x | 1.64x | $-20.36 Million |
| 2019 | 8.02% | 7.62% | 0.62x | 1.70x | $-27.60 Million |
| 2020 | 11.55% | 9.64% | 0.68x | 1.76x | $21.56 Million |
| 2021 | 15.90% | 12.17% | 0.74x | 1.76x | $91.57 Million |
| 2022 | 10.29% | 8.57% | 0.74x | 1.62x | $4.43 Million |
| 2023 | 9.29% | 9.08% | 0.65x | 1.58x | $-11.42 Million |
| 2024 | 4.04% | 4.72% | 0.50x | 1.71x | $-112.99 Million |
| 2025 | 5.17% | 5.07% | 0.60x | 1.69x | $-94.76 Million |
Industry Comparison
This section compares Ansell Limited's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,938,770,247
- Average return on equity (ROE) among peers: -36.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ansell Limited (ANSLF) | $1.98 Billion | -44.39% | 0.68x | $2.58 Billion |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |